There are 26 records that matched your search criteria

Date Title Category
13-Oct-2009 Caution Statement on “Increased Risk for Opportunistic Infections such as Activation of Latent Viral Infections Including BK Virus-Associated Nephropathy” required to be included in the product package insert for Immunosuppressant
Bil (44) dlm. BPFK/PPP/01/03 dated 13th October 2009 		DCA letters
22-Jul-2010 Caution Statement on "Boxed warning" must include Propylthiouracil with "Severe Liver Injury"
Bil (55) dlm. BPFK/PPP/01/03 dated 22nd Jul 2010 		DCA letters
23-Feb-2011 Briefing on 'Competition Act 2010'
by the Ms Shila Dorai Raj, Director of the Interim Competition Commission, MDTCC 		General News
15-Sep-2009 Advertisement on Products for nicotine replacement therapy with MAB Approval
Bil (37) dlm KKM-55/205/001/02 Jld 5 dated 15th Sept 2009 		MAB Letter
12-Nov-2009 8th List for BE Studies for Oral “Immediate Release” Generic Products
Bil (46) dlm. BPFK/PPP/01/03 dated 30th October 2009 		DCA letters
24-Mar-2016 44th PhAMA Annual General Meeting 2016